| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Rapamycin | CTRPv2 | pan-cancer | AAC | 0.0057 | 0.9 |
| mRNA | SCH-79797 | CTRPv2 | pan-cancer | AAC | 0.0058 | 0.9 |
| mRNA | AT-406 | CTRPv2 | pan-cancer | AAC | 0.0079 | 0.9 |
| mRNA | WZ4002 | CTRPv2 | pan-cancer | AAC | -0.007 | 0.9 |
| mRNA | GW-405833 | CTRPv2 | pan-cancer | AAC | 0.005 | 0.9 |
| mRNA | BRD-K35604418 | CTRPv2 | pan-cancer | AAC | 0.0054 | 0.9 |
| mRNA | myriocin | CTRPv2 | pan-cancer | AAC | 0.011 | 0.9 |
| mRNA | BRD-K20514654 | CTRPv2 | pan-cancer | AAC | 0.0068 | 0.9 |
| mRNA | BRD-K51831558 | CTRPv2 | pan-cancer | AAC | -0.0075 | 0.9 |
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | -0.035 | 0.9 |